Adenocarcinoma

"Adenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A malignant epithelial tumor with a glandular organization.

Descriptor ID	D000230
MeSH Number(s)	C04.557.470.200.025
Concept/Terms	Adenocarcinoma Adenocarcinoma Adenocarcinomas Adenoma, Malignant Adenomas, Malignant Malignant Adenoma Malignant Adenomas Carcinoma, Granular Cell Carcinoma, Granular Cell Carcinomas, Granular Cell Granular Cell Carcinoma Granular Cell Carcinomas Adenocarcinoma, Granular Cell Adenocarcinomas, Granular Cell Granular Cell Adenocarcinoma Granular Cell Adenocarcinomas Adenocarcinoma, Tubular Adenocarcinoma, Tubular Adenocarcinomas, Tubular Tubular Adenocarcinoma Tubular Adenocarcinomas Carcinoma, Tubular Carcinomas, Tubular Tubular Carcinoma Tubular Carcinomas Carcinoma, Cribriform Carcinoma, Cribriform Carcinomas, Cribriform Cribriform Carcinoma Cribriform Carcinomas Adenocarcinoma, Basal Cell Adenocarcinoma, Basal Cell Adenocarcinomas, Basal Cell Basal Cell Adenocarcinoma Basal Cell Adenocarcinomas Adenocarcinoma, Oxyphilic Adenocarcinoma, Oxyphilic Adenocarcinomas, Oxyphilic Oxyphilic Adenocarcinoma Oxyphilic Adenocarcinomas

Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]

Below are MeSH descriptors whose meaning is related to "Adenocarcinoma".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Adenocarcinoma" by people in this website by year, and whether "Adenocarcinoma" was a major or minor topic of these publications.

Bar chart showing 297 publications over 31 distinct years, with a maximum of 20 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	2	2	4
1993	5	0	5
1994	1	1	2
1995	5	3	8
1996	6	3	9
1997	3	2	5
1998	2	2	4
1999	8	6	14
2000	2	4	6
2001	5	3	8
2002	9	4	13
2003	8	3	11
2004	7	3	10
2005	8	4	12
2006	5	3	8
2007	9	3	12
2008	4	6	10
2009	10	4	14
2010	11	1	12
2011	12	2	14
2012	11	3	14
2013	11	3	14
2014	17	3	20
2015	12	2	14
2016	12	2	14
2017	16	2	18
2018	4	0	4
2019	6	1	7
2020	5	0	5
2021	4	0	4
2022	2	0	2

Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.

Popov A, Klimovich A, Styshova O, Tsybulsky A, Hushpulian D, Osipyants A, Khristichenko A, Kazakov S, Ahuja M, Kaidery N, Thomas B, Tishkov V, Brown A, Gazaryan I, Poloznikov A. Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2. Molecules. 2022 Jan 19; 27(3).

View in: PubMed
Safran HP, Winter K, Ilson DH, Wigle D, DiPetrillo T, Haddock MG, Hong TS, Leichman LP, Rajdev L, Resnick M, Kachnic LA, Seaward S, Mamon H, Diaz Pardo DA, Anderson CM, Shen X, Sharma AK, Katz AW, Salo J, Leonard KL, Moughan J, Crane CH. Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2022 02; 23(2):259-269.

View in: PubMed
Yang D, King W, Aihara H, Karasik MS, Ngamruengphong S, Aadam AA, Othman MO, Sharma N, Grimm IS, Rostom A, Elmunzer BJ, Jawaid SA, Perbtani YB, Hoffman BJ, Akki AS, Schlachterman A, Coman RM, Wang AY, Draganov PV. Effect of endoscopic submucosal dissection on histologic diagnosis in Barrett's esophagus visible neoplasia. Gastrointest Endosc. 2022 Apr; 95(4):626-633.

View in: PubMed
Zhuang E, Uchio E, Lilly M, Zi X, Fruehauf JP. A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer. Biomed Pharmacother. 2021 Nov; 143:112226.

View in: PubMed
Caldwell C, Rottman JB, Paces W, Bueche E, Reitsma S, Gibb J, Adisetiyo V, Haas MS, Heath H, Newman W, Baum J, Gianani R, Kagey MH. Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors. Sci Rep. 2021 05 10; 11(1):9920.

View in: PubMed
Garcia DI, Hurst KE, Bradshaw A, Janakiraman H, Wang C, Camp ER. High-Fat Diet Drives an Aggressive Pancreatic Cancer Phenotype. J Surg Res. 2021 08; 264:163-172.

View in: PubMed
Siegel J, Engelhardt KE, Hornor MA, Morgan KA, Lancaster WP. Travel distance and its interaction with patient and hospital factors in pancreas cancer care. Am J Surg. 2021 04; 221(4):819-825.

View in: PubMed
Reddy CA, Tavakkoli A, Chen VL, Korsnes S, Bedi AO, Carrott PW, Chang AC, Lagisetty KH, Kwon RS, Elmunzer BJ, Orringer MB, Piraka C, Prabhu A, Reddy RM, Wamsteker E, Rubenstein JH. Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett's Esophagus. Dig Dis Sci. 2021 05; 66(5):1580-1587.

View in: PubMed
Tavakkoli A, Elmunzer BJ, Waljee AK, Murphy CC, Pruitt SL, Zhu H, Rong R, Kwon RS, Scheiman JM, Rubenstein JH, Singal AG. Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous interventions. Gastrointest Endosc. 2021 01; 93(1):154-162.e5.

View in: PubMed
Sierra JC, Piazuelo MB, Luis PB, Barry DP, Allaman MM, Asim M, Sebrell TA, Finley JL, Rose KL, Hill S, Holshouser SL, Casero RA, Cleveland JL, Woster PM, Schey KL, Bimczok D, Schneider C, Gobert AP, Wilson KT. Spermine oxidase mediates Helicobacter pylori-induced gastric inflammation, DNA damage, and carcinogenic signaling. Oncogene. 2020 05; 39(22):4465-4474.

View in: PubMed

People

Explore

Similar Concepts

Top Journals